BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The Life Sciences Strategy Summit on IP and Exclusivity is a p
 remier annual event convening pharmaceutical\, biotech\, and legal profes
 sionals to explore the evolving landscape of intellectual property and re
 gulatory exclusivity. Scheduled for October 2025 in Munich\, Germany\, th
 e summit offers a platform for in-depth discussions on patent strategies\
 , regulatory frameworks\, and market exclusivity challenges.​\n\nAttendee
 s can anticipate sessions on the latest developments in Supplementary Pro
 tection Certificates (SPCs)\, including the implications of recent CJEU d
 ecisions and the SPC waiver's impact on both generic and innovator strate
 gies. The conference will also delve into the intersection of regulatory 
 and IP law\, with topics covering clinical trials\, data exclusivity\, an
 d the Pharmaceutical Strategy for Europe. Additionally\, panels will addr
 ess patentability requirements within the life sciences industry\, focusi
 ng on patent quality\, the G2/21 decision\, enablement\, and the role of 
 the Patent Trial and Appeal Board (PTAB). The influence of the Unified Pa
 tent Court (UPC) on life science strategies will also be a key discussion
  point\, featuring industry-led sessions and a judges panel .​\n\nPrecedi
 ng the main summit\, the SPC and PTE Forum offers a focused day on Octobe
 r 8\, 2025\, dedicated to SPC strategies\, including updates on litigatio
 n\, the Unitary SPC proposal\, and foundational knowledge essential for p
 atent practitioners .​\n\nWith over 65 speakers and participants from mor
 e than 26 countries\, the summit provides unparalleled networking opportu
 nities and insights into shaping robust IP and regulatory strategies for 
 the future .​\n\nURLs:Tickets: https://go.evvnt.com/3007159-0?pid=185Broc
 hure: https://go.evvnt.com/3007159-3?pid=185Sponsor: https://go.evvnt.com
 /3007159-4?pid=185Website: https://go.evvnt.com/3007159-5?pid=185\n\nTime
 : 8:00 AM - 6:00 PM\n\nPrices:Tier 1 - In-House Counsels: EUR 499.00\,Tie
 r 2 - All Other (2 Day Conference Pass): EUR 1399.00\,Tier 2 - All Other 
 (3 Day Conference Pass): EUR 1799.00\,One Day Pass: EUR 999.00\n\nSpeaker
 s: Julia Pike\, Global Head of IP\, Sandoz\, Toni Santamaria\, SVP - IP a
 nd Legal\, Adalvo\, James Horgan\, Chief IP Counsel\, MSD\, Nicolas Ruiz\
 , Head of IP\, Esteve\, Tamaris Bucher\, Principal Patent Counsel\, Novar
 tis\, Natalia Wright\, Associate General Patent Counsel\, UCB\, Andreas R
 obinson\, Senior IP Counsel\, Amgen\, Dorian Immler\, Head of Patents- Ph
 arma\, Bayer\, Ana Gabarda\, Director- Corporate Patent Counsel\, Merck\,
  Oliver Werner\, Head of SPC Working Group\, German Patent and Trade Mark
  Office\n
DTEND:20251015T180000
DTSTAMP:20260512T225915Z
DTSTART:20251013T080000
LOCATION:INFINITY\, 1-3 Andreas-Danzer-Weg\, Unterschleißheim\, Bayern\, 8
 5716\,
SEQUENCE:0
SUMMARY:The Life Sciences Strategy Summit on IP and Exclusivity is a premi
 er annual event convening pharmaceutical\, biotech\, and legal profession
 als to exp...
UID:2d690351-3602-407a-b97d-15d0d3c84778
END:VEVENT
END:VCALENDAR